Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Sinnathamby, MA"'
Autor:
Webster, HH, Nyberg, T, Sinnathamby, MA, Aziz, N Abdul, Ferguson, N, Seghezzo, G, Blomquist, PB, Bridgen, J, Chand, M, Groves, N, Myers, R, Hope, R, Ashano, E, Lopez-Bernal, J, De Angelis, D, Dabrera, G, Presanis, AM, Thelwall, S
The Omicron variant of SARS-CoV-2 became the globally dominant variant in early 2022. A sub-lineage of the Omicron variant (BA.2) was identified in England in January 2022. Here, we investigated hospitalisation and mortality risks of COVID-19 cases w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ceb10806fa9a5a471abca4235f3e64f1
https://www.repository.cam.ac.uk/handle/1810/343325
https://www.repository.cam.ac.uk/handle/1810/343325
Autor:
Sinnathamby MA; Respiratory Virus Section, Immunisation and Vaccine-Preventable Diseases Division, Public Health Programmes, United Kingdom Health Security Agency (UKHSA), London, United Kingdom., Bourouphael T; Respiratory Virus Section, Immunisation and Vaccine-Preventable Diseases Division, Public Health Programmes, United Kingdom Health Security Agency (UKHSA), London, United Kingdom., Boateng J; Respiratory Virus Section, Immunisation and Vaccine-Preventable Diseases Division, Public Health Programmes, United Kingdom Health Security Agency (UKHSA), London, United Kingdom., Collonnaz M; Respiratory Virus Section, Immunisation and Vaccine-Preventable Diseases Division, Public Health Programmes, United Kingdom Health Security Agency (UKHSA), London, United Kingdom., Quinot C; Respiratory Virus Section, Immunisation and Vaccine-Preventable Diseases Division, Public Health Programmes, United Kingdom Health Security Agency (UKHSA), London, United Kingdom., Aziz NA; Respiratory Virus Section, Immunisation and Vaccine-Preventable Diseases Division, Public Health Programmes, United Kingdom Health Security Agency (UKHSA), London, United Kingdom., Elgohari S; Respiratory Virus Section, Immunisation and Vaccine-Preventable Diseases Division, Public Health Programmes, United Kingdom Health Security Agency (UKHSA), London, United Kingdom., Green RE; Respiratory Virus Section, Immunisation and Vaccine-Preventable Diseases Division, Public Health Programmes, United Kingdom Health Security Agency (UKHSA), London, United Kingdom., Dabrera G; Respiratory Virus Section, Immunisation and Vaccine-Preventable Diseases Division, Public Health Programmes, United Kingdom Health Security Agency (UKHSA), London, United Kingdom., Lopez-Bernal J; Respiratory Virus Section, Immunisation and Vaccine-Preventable Diseases Division, Public Health Programmes, United Kingdom Health Security Agency (UKHSA), London, United Kingdom., Allen A; Respiratory Virus Section, Immunisation and Vaccine-Preventable Diseases Division, Public Health Programmes, United Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Publikováno v:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2024 Nov; Vol. 29 (45).
Autor:
Ikejezie J; Health Emergencies Programme, World Health Organization, Geneva, Switzerland ikejeziej@who.int., Miglietta A; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Hammermeister Nezu I; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Adele S; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Higdon MM; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Feikin D; Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland., Lata H; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Mesfin S; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Idoko F; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Shimizu K; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Acma A; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Moro S; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Attar Cohen H; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Sinnathamby MA; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Otieno JR; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Temre Y; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Ajong BN; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Mirembe BB; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Guinko TN; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Sodagar V; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Schultz C; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Muianga J; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., De Barros S; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Escobar Corado Waeber AR; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Jin Y; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Rico Chinchilla A; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Izawa Y; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Khare S; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Poole M; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Alexander N; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Ciobanu S; World Health Organization Regional Office for Europe, Copenhagen, Denmark., Dorji T; World Health Organization Regional Office for South-East Asia, New Delhi, India., Hassan M; World Health Organisation Regional Office for the Eastern Mediterranean, Cairo, Egypt., Kato M; World Health Organization Regional Office for South-East Asia, New Delhi, India., Matsui T; World Health Organization Regional Office for the Western Pacific, Manila, Philippines., Ogundiran O; World Health Organization Regional Office for Africa, Brazzaville, Congo., Pebody RG; World Health Organization Regional Office for Europe, Copenhagen, Denmark., Phengxay M; World Health Organization Regional Office for the Western Pacific, Manila, Philippines., Riviere-Cinnamond A; World Health Organization Regional Office for the Americas, Washington, DC, USA., Greene-Cramer BJ; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Peron E; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Archer BN; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Subissi L; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Kassamali ZA; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Awofisayo-Okuyelu A; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., le Polain de Waroux O; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Hamblion E; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Pavlin BI; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Morgan O; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Fall IS; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Van Kerkhove MD; Health Emergencies Programme, World Health Organization, Geneva, Switzerland., Mahamud A; Health Emergencies Programme, World Health Organization, Geneva, Switzerland.
Publikováno v:
BMJ global health [BMJ Glob Health] 2024 Apr 04; Vol. 9 (4). Date of Electronic Publication: 2024 Apr 04.
Autor:
Sinnathamby MA; COVID-19 Vaccines and Epidemiology Division, Public Health Programmes Directorate UK Health Security Agency London UK., Zaidi A; COVID-19 Vaccines and Epidemiology Division, Public Health Programmes Directorate UK Health Security Agency London UK., Twohig KA; COVID-19 Vaccines and Epidemiology Division, Public Health Programmes Directorate UK Health Security Agency London UK., Aliabadi S; COVID-19 Vaccines and Epidemiology Division, Public Health Programmes Directorate UK Health Security Agency London UK., Aziz NA; COVID-19 Vaccines and Epidemiology Division, Public Health Programmes Directorate UK Health Security Agency London UK., Groves N; Genomics Public Health Analysis, TARZET Division, Clinical and Emerging Infections Directorate UK Health Security Agency London UK., Gallagher E; Genomics Public Health Analysis, TARZET Division, Clinical and Emerging Infections Directorate UK Health Security Agency London UK., Thelwall S; COVID-19 Vaccines and Epidemiology Division, Public Health Programmes Directorate UK Health Security Agency London UK., Dabrera G; COVID-19 Vaccines and Epidemiology Division, Public Health Programmes Directorate UK Health Security Agency London UK.
Publikováno v:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2023 Nov; Vol. 17 (11), pp. e13204.
Autor:
Sinnathamby MA; UK Health Security Agency, London, UK., Warburton F; UK Health Security Agency, London, UK., Guy R; UK Health Security Agency, London, UK., Andrews N; UK Health Security Agency, London, UK., Lamagni T; UK Health Security Agency, London, UK., Watson C; UK Health Security Agency, London, UK., Bernal JL; UK Health Security Agency, London, UK.
Publikováno v:
Open forum infectious diseases [Open Forum Infect Dis] 2023 May 18; Vol. 10 (6), pp. ofad270. Date of Electronic Publication: 2023 May 18 (Print Publication: 2023).
Autor:
Sinnathamby MA; UK Health Security Agency London UK., Warburton F; UK Health Security Agency London UK., Reynolds AJ; Public Health Scotland Glasgow UK., Cottrell S; Public Health Wales Cardiff UK., O'Doherty M; Public Health Agency Northern Ireland Belfast UK., Domegan L; Health Service Executive-Health Protection Surveillance Centre Dublin Ireland., O'Donnell J; Health Service Executive-Health Protection Surveillance Centre Dublin Ireland., Johnston J; Public Health Agency Northern Ireland Belfast UK., Yonova I; Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) London UK.; University of Surrey Guilford UK., Elgohari S; UK Health Security Agency London UK., Boddington NL; UK Health Security Agency London UK., Andrews N; UK Health Security Agency London UK., Ellis J; UK Health Security Agency London UK., de Lusignan S; Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) London UK.; University of Surrey Guilford UK.; University of Oxford UK., McMenamin J; Public Health Scotland Glasgow UK., Pebody RG; UK Health Security Agency London UK.
Publikováno v:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2023 Feb 13; Vol. 17 (2), pp. e13099. Date of Electronic Publication: 2023 Feb 13 (Print Publication: 2023).
Autor:
Webster HH; UKHSA COVID-19 National Epidemiology Cell, London, UK., Nyberg T; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK., Sinnathamby MA; UKHSA COVID-19 National Epidemiology Cell, London, UK., Aziz NA; UKHSA COVID-19 National Epidemiology Cell, London, UK., Ferguson N; NIHR Health Protection Research Unit for Modelling and Health Economics, MRC Centre for Global Infectious Disease Analysis, Jameel Institute, Imperial College London, London, UK., Seghezzo G; UKHSA COVID-19 National Epidemiology Cell, London, UK., Blomquist PB; UKHSA Outbreak Surveillance Team, London, UK., Bridgen J; UKHSA Outbreak Surveillance Team, London, UK., Chand M; UKHSA Genomics and Public Health Analysis, London, UK., Groves N; UKHSA Genomics and Public Health Analysis, London, UK., Myers R; UKHSA Genomics and Public Health Analysis, London, UK., Hope R; UKHSA COVID-19 National Epidemiology Cell, London, UK., Ashano E; UKHSA HCAI, Fungal, AMR, AMU & Sepsis Division, London, UK., Lopez-Bernal J; UKHSA COVID-19 Surveillance Cell, London, UK.; NIHR Health Protection Research Unit for Respiratory Infections, London, UK., De Angelis D; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.; UKHSA Statistics, Modelling and Economics Department, London, UK.; UKHSA Joint Modelling Team, London, UK.; NIHR Health Protection Research Unit for Behavioural Science and Evaluation, Bristol, UK., Dabrera G; UKHSA COVID-19 National Epidemiology Cell, London, UK., Presanis AM; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK., Thelwall S; UKHSA COVID-19 National Epidemiology Cell, London, UK. feedback.c19epi@ukhsa.gov.uk.
Publikováno v:
Nature communications [Nat Commun] 2022 Oct 13; Vol. 13 (1), pp. 6053. Date of Electronic Publication: 2022 Oct 13.
Autor:
Sinnathamby MA; Immunisation and Countermeasures, National Infection Service, Public Health England (PHE), London, UK., Warburton F; Statistics and Modelling Department, National Infection Service, Public Health England (PHE), London, UK., Andrews N; Statistics and Modelling Department, National Infection Service, Public Health England (PHE), London, UK., Boddington NL; Immunisation and Countermeasures, National Infection Service, Public Health England (PHE), London, UK., Zhao H; Immunisation and Countermeasures, National Infection Service, Public Health England (PHE), London, UK., Ellis J; Virus Reference Department, National Infection Service, Public Health England (PHE), London, UK., Tessier E; Immunisation and Countermeasures, National Infection Service, Public Health England (PHE), London, UK., Donati M; National Infection Service Laboratories, National Infection Service, Public Health England (PHE), Bristol, UK., Elliot AJ; Real-Time Syndromic Surveillance Team, National Infection Service, Public Health England (PHE), Birmingham, UK., Hughes HE; Real-Time Syndromic Surveillance Team, National Infection Service, Public Health England (PHE), Birmingham, UK., Byford R; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; Research and Surveillance Centre (RSC), Royal College of General Practitioners (RCGP), London, UK., Smith GE; Real-Time Syndromic Surveillance Team, National Infection Service, Public Health England (PHE), Birmingham, UK., Tripathy M; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; Research and Surveillance Centre (RSC), Royal College of General Practitioners (RCGP), London, UK., de Lusignan S; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; Research and Surveillance Centre (RSC), Royal College of General Practitioners (RCGP), London, UK., Zambon M; Virus Reference Department, National Infection Service, Public Health England (PHE), London, UK., Pebody RG; Immunisation and Countermeasures, National Infection Service, Public Health England (PHE), London, UK.
Publikováno v:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2022 Jan; Vol. 16 (1), pp. 113-124. Date of Electronic Publication: 2021 Aug 17.
Autor:
Twohig KA; COVID-19 National Epidemiology Cell, Public Health England, London, UK. Electronic address: feedback.c19epi@phe.gov.uk., Nyberg T; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK., Zaidi A; COVID-19 National Epidemiology Cell, Public Health England, London, UK., Thelwall S; COVID-19 National Epidemiology Cell, Public Health England, London, UK., Sinnathamby MA; COVID-19 National Epidemiology Cell, Public Health England, London, UK., Aliabadi S; COVID-19 National Epidemiology Cell, Public Health England, London, UK., Seaman SR; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK., Harris RJ; Statistics, Modelling and Economics Department, Public Health England, London, UK., Hope R; COVID-19 National Epidemiology Cell, Public Health England, London, UK., Lopez-Bernal J; Immunisation and Countermeasures Division, Public Health England, London, UK., Gallagher E; COVID-19 Genomic Analysis Cell, Public Health England, London, UK., Charlett A; Statistics, Modelling and Economics Department, Public Health England, London, UK; Joint Modelling Team, Public Health England, London, UK., De Angelis D; Statistics, Modelling and Economics Department, Public Health England, London, UK; Joint Modelling Team, Public Health England, London, UK; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK., Presanis AM; Joint Modelling Team, Public Health England, London, UK; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK., Dabrera G; COVID-19 National Epidemiology Cell, Public Health England, London, UK.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Jan; Vol. 22 (1), pp. 35-42. Date of Electronic Publication: 2021 Aug 27.
Autor:
Muller-Pebody B; Healthcare Associated Infections and Antimicrobial Resistance Division, National Infection Service, Public Health England (PHE), London, United Kingdom., Sinnathamby MA; Immunisation and Countermeasures, National Infection Service, Public Health England (PHE), London, United Kingdom. Electronic address: mary.sinnathamby@phe.gov.uk., Warburton F; Statistics and Modelling Department, National Infection Service, Public Health England (PHE), London, United Kingdom., Rooney G; Healthcare Associated Infections and Antimicrobial Resistance Division, National Infection Service, Public Health England (PHE), London, United Kingdom., Andrews N; Statistics and Modelling Department, National Infection Service, Public Health England (PHE), London, United Kingdom., Whitaker H; Statistics and Modelling Department, National Infection Service, Public Health England (PHE), London, United Kingdom., Henderson KL; Healthcare Associated Infections and Antimicrobial Resistance Division, National Infection Service, Public Health England (PHE), London, United Kingdom., Tsang C; Immunisation and Countermeasures, National Infection Service, Public Health England (PHE), London, United Kingdom., Hopkins S; Healthcare Associated Infections and Antimicrobial Resistance Division, National Infection Service, Public Health England (PHE), London, United Kingdom., Pebody RG; Immunisation and Countermeasures, National Infection Service, Public Health England (PHE), London, United Kingdom.
Publikováno v:
Vaccine [Vaccine] 2021 Oct 29; Vol. 39 (45), pp. 6622-6627. Date of Electronic Publication: 2021 Oct 07.